Investigating a protein's role in dementia after brain bleeding.
Targeting receptor interacting protein kinase-1 in the chronic period of intracerebral hemorrhage
This study is looking at how a protein called RIPK-1 might play a role in memory problems for younger people who have had a brain bleed, with the goal of finding ways to help prevent dementia in these patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11000856 on NIH RePORTER |
What this research studies
This research focuses on understanding how a specific protein, receptor interacting protein kinase-1 (RIPK-1), contributes to cognitive decline in patients who have experienced intracerebral hemorrhage (ICH). The study aims to uncover the mechanisms behind the rapid progression to dementia observed in ICH survivors, particularly in younger individuals. By examining the effects of RIPK-1 on the blood-brain barrier and cognitive function, the research seeks to identify potential therapeutic targets for preventing dementia in these patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced an intracerebral hemorrhage and are at risk of developing vascular cognitive impairment or dementia.
Not a fit: Patients who have not experienced an intracerebral hemorrhage or those with other forms of dementia unrelated to vascular issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent or slow down dementia in patients who have suffered from intracerebral hemorrhage.
How similar studies have performed: Other research has shown promising results in targeting similar pathways in dementia, suggesting that this approach could be effective.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Whalen, Michael J — Massachusetts General Hospital
- Study coordinator: Whalen, Michael J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.